imedR 0.3.3

DOI

imedR is a manuscript-grade, guardrail-first R package for the Indian Microplastics Evidence Database (IMED).

Frozen v1.0 snapshot represented in this build

The bundled analytical snapshot is generated directly from IMED_v1.0_FROZEN.xlsx; workflow and extraction-log sheets are excluded.

Capabilities

Core rule

Validate -> define a scientifically compatible analysis set -> analyse -> visualize -> retrieve provenance/citations.

The package is designed to stop analyses that look computationally possible but are scientifically indefensible.

Validation status

The test suite passes (27 tests, 0 failures, 0 warnings, 0 skipped), and the IMED v1.0 relational integrity checks report no ERROR-level failures. R CMD check --as-cran was run on the Windows build service (win-builder, R 4.6.1, 8 October 2026) for version 0.3.1 and returned no errors and no warnings; the only note was the standard “New submission” note for a package not yet on CRAN.

Release-normalization note (v0.3.1)

The bundled frozen IMED v1.0 source snapshot is preserved. At load time, imedR removes wholly empty export rows and disambiguates the second genuine ST0064 size-method record from SZ0064-01 to runtime ID SZ0064-02. This is an identifier-only normalization; no scientific value is altered.

Installation

# install.packages("remotes")
remotes::install_github("ChanikyaNaiduCN7/imedR")
library(imedR)
imed_version()

Optional packages for mapping, meta-analysis and tables (sf, metafor, gt) are installed only if you use those functions.

Citation

Naidu C (2026). imedR: Guarded Evidence Synthesis for the Indian Microplastics Evidence Database. R package version 0.3.3. https://doi.org/10.5281/zenodo.23236915

Please also cite IMED/IMEA v1.0 (https://doi.org/10.5281/zenodo.23180568) and the original primary publications for any study-specific claim.

License

Package code: MIT (see LICENSE). The IMED/IMEA data release is licensed separately (see LICENSE_AND_REUSE.md in the data release). Third-party source rights remain with the original rights holders.

Release limitations

IMED v1.0 did not complete a second-review round, and no second-review PASS is claimed. See RELEASE_NOTES_v1.0.md in the data release.